Glenmede Trust Co. NA Increases Stock Holdings in Agilent Technologies, Inc. (NYSE:A)

Glenmede Trust Co. NA boosted its stake in Agilent Technologies, Inc. (NYSE:A) by 54.1% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 114,638 shares of the medical research company’s stock after buying an additional 40,231 shares during the quarter. Glenmede Trust Co. NA’s holdings in Agilent Technologies were worth $17,021,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the stock. Menard Financial Group LLC grew its holdings in shares of Agilent Technologies by 1.6% in the second quarter. Menard Financial Group LLC now owns 4,845 shares of the medical research company’s stock valued at $628,000 after acquiring an additional 77 shares in the last quarter. McAdam LLC boosted its position in Agilent Technologies by 3.1% in the third quarter. McAdam LLC now owns 2,531 shares of the medical research company’s stock worth $376,000 after purchasing an additional 77 shares during the last quarter. Brown Brothers Harriman & Co. grew its stake in Agilent Technologies by 13.5% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 646 shares of the medical research company’s stock valued at $96,000 after purchasing an additional 77 shares during the period. Global Retirement Partners LLC increased its position in shares of Agilent Technologies by 3.2% during the 3rd quarter. Global Retirement Partners LLC now owns 2,570 shares of the medical research company’s stock valued at $382,000 after purchasing an additional 79 shares during the last quarter. Finally, Rovin Capital UT ADV raised its stake in shares of Agilent Technologies by 1.6% during the 3rd quarter. Rovin Capital UT ADV now owns 5,049 shares of the medical research company’s stock worth $750,000 after purchasing an additional 81 shares during the period. 87.42% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of analysts recently issued reports on A shares. Sanford C. Bernstein decreased their price objective on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a report on Tuesday. TD Cowen raised their price target on shares of Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Bank of America upped their price objective on Agilent Technologies from $140.00 to $147.00 and gave the company a “neutral” rating in a research note on Thursday, August 22nd. Wells Fargo & Company began coverage on Agilent Technologies in a research report on Tuesday, August 27th. They issued an “overweight” rating and a $157.00 target price for the company. Finally, UBS Group upped their price target on Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a research report on Thursday, August 22nd. One analyst has rated the stock with a sell rating, seven have issued a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat, Agilent Technologies currently has an average rating of “Hold” and a consensus price target of $143.40.

Agilent Technologies Stock Performance

NYSE A opened at $138.14 on Friday. The company’s 50 day simple moving average is $137.65 and its two-hundred day simple moving average is $137.44. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37. Agilent Technologies, Inc. has a 1 year low of $124.10 and a 1 year high of $155.35. The stock has a market capitalization of $39.69 billion, a PE ratio of 28.66, a P/E/G ratio of 5.91 and a beta of 1.07.

Agilent Technologies Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st will be given a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.72%. The ex-dividend date of this dividend is Tuesday, December 31st. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.24. Agilent Technologies’s dividend payout ratio (DPR) is 20.54%.

Insider Activity at Agilent Technologies

In other news, SVP Dominique Grau sold 9,990 shares of the stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the transaction, the senior vice president now owns 40,011 shares of the company’s stock, valued at $5,801,595. This represents a 19.98 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.33% of the stock is owned by corporate insiders.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.